Disruption of immune responses by type 1 diabetes exacerbates SARS-CoV-2 mediated lung injury
Open Access
- 1 December 2024
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 327 (6) , L839-L851
Abstract
We define the exacerbating effects of type 1 diabetes mellitus (T1DM) on COVID-19 pneumonia severity in mice. Hyperglycemic mice experienced increased weight loss and reduced oxygen saturation. Transcriptomic analysis revealed impaired immune responses in diabetic mice, while flow cytometry and single-cell RNA sequencing confirmed reduced T-cell recruitment and an inflammatory macrophage profile. In addition, we introduced a novel technique for tissue analysis, enabling flow cytometric analysis on highly fixed tissue samples.Keywords
All Related Versions
Funding Information
- HHS | NIH | NHLBI | Division of Intramural Research (5T32-HL007586-38)
- University of Pennsylvania (Institute for Infectious and Zoonotic Disease Pilot Grant)
- University of Pennsylvania (Institute for Translational Medicine and Therapeutics Pilot Grant)
This publication has 38 references indexed in Scilit:
- Influenza: Diabetes as a risk factor for severe related-outcomes and the effectiveness of vaccination in diabetic population. A meta-analysis of observational studiesNutrition, Metabolism and Cardiovascular Diseases, 2023
- Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the USJAMA Network Open, 2023
- ΔNp63 drives dysplastic alveolar remodeling and restricts epithelial plasticity upon severe lung injuryCell Reports, 2022
- Guidance on Processing the 10x Genomics Single Cell Gene Expression Assay2022
- Integrated analysis of multimodal single-cell dataCell, 2021
- Elevated HbA1c levels in pre‐Covid‐19 infection increases the risk of mortality: A systematic review and meta‐analysisDiabetes/Metabolism Research and Reviews, 2021
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort studyThe Lancet Diabetes & Endocrinology, 2020
- Clinical manifestations and outcomes of respiratory syncytial virus infection in adult hospitalized patientsJournal of Clinical Virology, 2019
- The global diabetes epidemic: what does it mean for infectious diseases in tropical countries?The Lancet Diabetes & Endocrinology, 2017
- Diabetes and infection: assessing the association with glycaemic control in population-based studiesThe Lancet Diabetes & Endocrinology, 2016